US Stock MarketDetailed Quotes

CANF Can-Fite BioPharma

Watchlist
  • 1.6000
  • +0.0900+5.96%
Close Mar 21 16:00 ET
  • 1.5600
  • -0.0400-2.50%
Post 19:42 ET
9.75MMarket Cap-0.62P/E (TTM)

Can-Fite BioPharma Key Stats

Can-Fite BioPharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 150.000K--
--2024/Q1-- / 150.000K--
--2023/Q4155.000K / 200.000K--
--2023/Q3196.000K / 200.000K--
--2023/Q2196.000K / 200.000K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 150.000K--
--2024/Q1-- / 150.000K--
--2023/Q4155.000K / 200.000K--
--2023/Q3196.000K / 200.000K--
--2023/Q2196.000K / 200.000K--

Unlock Free Earnings Estimates

Can-Fite BioPharma Earnings Reports

Read more

Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Feb 28, 2025

Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data